Plasmacytoid variant urothelial bladder cancer: Is it time to update the treatment paradigm? 1 Contributed equally to manuscript.

Plasmacytoid variant (PCV) urothelial cancer (UC) of the bladder is rare, with poor clinical outcomes. We sought to identify factors that may better inform expectations of tumor behavior and improve management options in patients with PCV UC.